Lamotrigine Tablet
Product Images NDC 51672-4131

16 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 51672-4131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine 01)

Chemical Structure (Lamotrigine 01)
Chemical structure of lamotrigine, showing a triazine ring bonded to a phenyl ring with two chlorine atoms and amino substituents.*
FDA Label Image

Figure 1 (Lamotrigine 02)

Figure 1 (Lamotrigine 02)
A line graph depicting failure probability (%) over time (weeks) comparing Lamotrigine and placebo groups. The graph shows two survival curves with Lamotrigine having a lower failure probability than placebo across the weeks, with censored data points marked on the curves.*
FDA Label Image

Figure 2 (Lamotrigine 03)

Figure 2 (Lamotrigine 03)
A Kaplan-Meier curve chart showing failure probability (%) over weeks for Lamotrigine versus Placebo. The y-axis represents failure probability from 0 to 100%, and the x-axis shows time in weeks from 0 to 80. The chart includes censored data points and demonstrates different survival curves for Lamotrigine and Placebo groups.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg1)

Tabs (Lamo Tabs Med Guide Pg1)
Medication guide for Lamotrigine Tablets, USP, providing detailed warnings about serious skin rashes, allergic reactions, blood and liver problems, heart issues, and potential suicidal thoughts or actions. It advises patients to contact healthcare providers if they experience symptoms such as skin rash, fever, chest pain, or mood changes. The guide includes risk factors and symptoms requiring immediate medical attention.*
FDA Label Image

Tabs (Lamo Tabs Med Guid Pg2)

Tabs (Lamo Tabs Med Guid Pg2)
This image displays safety information and warnings about Lamotrigine tablets, including serious side effects such as suicidal thoughts and aseptic meningitis. It emphasizes verifying the correct medication due to similar drug names, and includes images and physical descriptions of Lamotrigine tablets USP in strengths 25 mg, 100 mg, 150 mg, and 200 mg, highlighting their round shape, scoring, color, and engravings.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg3)

Tabs (Lamo Tabs Med Guide Pg3)
This text panel provides information about lamotrigine, including its use as a prescription medicine for certain types of seizures and bipolar I disorder mood stabilization. It details precautions such as not taking the medication if allergic, and advises patients to inform healthcare providers about specific health conditions and medication use. Safety considerations for pregnancy and breastfeeding are also mentioned.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg.3.5)

Tabs (Lamo Tabs Med Guide Pg.3.5)
A text panel providing instructions on how to take Lamotrigine tablets. It advises taking the medication exactly as prescribed, not changing the dose without consulting a healthcare provider, not stopping suddenly due to risk of serious problems, and proper steps if a dose is missed. It emphasizes not taking two doses at the same time.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg 4)

Tabs (Lamo Tabs Med Guide Pg 4)
This text panel provides detailed patient information for Lamotrigine tablets, including instructions on overdose response, side effects, precautions for use, storage conditions (20° to 25°C), and advice to keep the medication out of reach of children. It lists common side effects, storage guidelines, inactive ingredients, manufacturer details, and contact information for further inquiries, without dosing or clinical claims.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
Lamotrigine Tablets, USP 25 mg oral tablets. The label includes dosage strength, directions to dispense the accompanying Medication Guide, storage instructions, and manufacturer details listing Taro Pharmaceutical Industries Ltd. in Israel and Taro Pharmaceuticals U.S.A., Inc. in Hawthorne, NY. The NDC number and a barcode are also present.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Lamotrigine Tablets, USP 100 mg oral tablets packaging label. The label indicates a quantity of 100 tablets and includes caution text to verify the product dispensed. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label features storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Principal Display Panel (150 mg Tablet Bottle Label)
Lamotrigine Tablets USP 150 mg oral tablets label showing a package of 60 tablets. Label includes instructions to dispense the accompanying medication guide, storage conditions at 20° to 25°C, and cautions to verify the product dispensed. The label lists the manufacturer as Taro Pharmaceutical Industries Ltd and distributor as Taro Pharmaceuticals U.S.A., Inc.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Lamotrigine Tablets USP 200 mg oral tablets packaging label showing 60 tablets per container. The label includes storage instructions and states the product is Rx only. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc.*
FDA Label Image

20 mg-sun (Lamotrigine Tablets 25mg 100 Tablets)

20 mg-sun (Lamotrigine Tablets 25mg 100 Tablets)
Lamotrigine Tablets, USP 25 mg oral tablet label showing 100 tablets per container. Label displays warnings to verify the product dispensed, storage instructions at 20° to 25°C, and manufacturer information by Taro Pharmaceutical Industries Ltd. with distribution by Sun Pharmaceutical Industries, Inc. The label includes a barcode and the Sun Pharma logo.*
FDA Label Image

Bottle Label (Lamotrigine Tablets 100mg 100 Tablets)

Bottle Label (Lamotrigine Tablets 100mg 100 Tablets)
Label for Lamotrigine Tablets, USP 100 mg oral tablets. The label indicates the product contains 100 tablets and is distributed by Sun Pharmaceutical Industries, Inc. It features storage instructions and a caution to verify the product dispensed. Manufactured by Taro Pharmaceutical Industries Ltd., Israel. Includes a barcode and the NDC number 51672-4131-1.*
FDA Label Image

150 mg (sun)

150 mg (sun)
Label for Lamotrigine Tablets, USP, 150 mg oral tablets in a package of 60 tablets. The label includes a caution to verify the product dispensed and to provide the accompanying Medication Guide to each patient. It shows the NDC 51672-4132-4 and is distributed by Sun Pharmaceutical Industries, Inc., with manufacturing by Taro Pharmaceutical Industries Ltd. Storage instructions specify keeping the tablets between 20° to 25°C (68° to 77°F) in a dry place, protected from light.*
FDA Label Image

Bottle Label (Lamotrigine Tablets 200mg 60 Tablets)

Bottle Label (Lamotrigine Tablets 200mg 60 Tablets)
Label for Lamotrigine Tablets, USP 200 mg oral tablets distributed by Sun Pharmaceutical Industries, Inc. The label indicates a package containing 60 tablets with a caution to verify product dispensed and to provide an accompanying Medication Guide. Manufacturer details include Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel. Storage instructions specify 20° to 25°C (68° to 77°F) in a dry, light-protected place.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.